1 / 19

Le Complément

Le Complément. Dr Alessandra Rosenthal Laboratoire Central d’Immunologie (Prof. A. Bernard) CHU de Nice. Système Immunitaire. Immunité naturelle Immunité acquise. Immunité Naturelle. Composants cellulaires : Cellules phagocytaires (neutro, mono, macrophages)

tuvya
Télécharger la présentation

Le Complément

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Le Complément Dr Alessandra Rosenthal Laboratoire Central d’Immunologie (Prof. A. Bernard) CHU de Nice

  2. Système Immunitaire Immunité naturelle Immunité acquise

  3. Immunité Naturelle • Composants cellulaires : • Cellules phagocytaires (neutro, mono, macrophages) • Cellules relarguant des médiateurs (baso, eosino, mast cells) • Cellules NK • Composants moléculaires : • Complément • Protéines de la phase aïgue • Cytokines (IFN etc)

  4. Les trois voies d’activation du Complément Voie Initiateurs Classique Immuno-complexes Cellules apoptotiques Certains virus et bacteries Gram- CRP liée au ligand des lectines Microorganismes avec groupements mannoses terminaux Alterne Bactéries, champignons, virus, cellules tumorales

  5. Activation du Complément Walport NEJM 2001

  6. Assembly of C1 during the Classical Complement Pathway The Fab of IgG or IgM bind to epitopes on an antigen. C1q, C1r, and C1s then assembles on the Fc portion of the antibodies to form C1, the first enzyme of the classical complement pathway. The enzyme C1 is able to cleave C4 into C4a and C4b, as well as C2 into C2a and C2b.

  7. Formation of C3 Convertase during the Classical Complement Pathway The enzyme C1 is able to cleave C4 into C4a and C4b. The C4b binds to adjacent proteins and carbohydrates on the surface of the antigen. C2 then binds to the C4b and C1 cleaves C2 into C2a and C2b. The C4a2b functions as a C3 convertase that can subsequently cleave hundreds of molecules of C3 and C3b.

  8. Formation of C5 Convertase during the Classical Complement Pathway The C4a2b functions as a C3 convertase that can subsequently cleave hundreds of molecules of C3 into C3a and C3b. Much of the C3b binds to adjacent proteins and carbohydrates on the antigen to participate in opsonization while C3a can stimulate inflammatory responses. Some of the C3b binds to C4b2a to form C4b2a3b, a C5 convertase that can cleave C5 into C5a and C5b.

  9. The Membrane Attack Complex (MAC) Causing Cell Lysis This C5b6789membrane attack complex (MAC), puts pores into lipid bilayer membranes of human cells to which antibodies have bound. This results in cell lysis. MAC can also damage the envelope of enveloped viruses and put pores in the outer membrane and cytoplasmic membrane of gram-negative bacteria causing their lysis

  10. Activation of the alternative complement pathwayand formation of C3 convertase Activation of the alternative complement pathway begins when C3b (or C3i) binds to the cell wall and other surface components of microbes. Alternative pathway protein Factor B then combines with the cell-bound C3b to form C3bB. Factor D then splits the bound Factor B into Bb and Ba, forming C3bBb. A serum protein called properdin then binds to the Bb to form C3bBbP that functions as a C3 convertase capable of enzymatically splitting hundreds of molecules of C3 into C3a and C3b.

  11. Formation of C5 convertase during the alternative complement pathway Some of the C3b subsequently binds to some of the C3bBb to form C3bBb3b, a C5 convertase capable of enzymatically splitting hundreds of molecules of C5 into C5a and C5b

  12. Régulation duclivage of C3 par le Factor H et Factor I Walport NEJM 2001

  13. Les trois principales activités physiologiques du système complémentaire Activité Protéines responsables Défense contre les infections : Opsonisation C3 et C4 Chimiotactisme et activation Anaphylotoxines (C5a, C3a et C4a) Lyse des bactéries et des cellules MAC (C5b-C9) Interface entre immunité naturelles et spécifique : Augmentation de la réponse Ab C3b et C4b liés aux CI; C3R sur B et APC Potentialisation de la mémoire Imm. C3b et C4b liés aux CI; C3R sur FDC Élimination des cellules endommagées: Clearance des CI dans les tissus C1q; fragments de C3 et C4 Clearance des cellules apoptotiques C1q; fragments de C3 et C4

  14. Opsonization of a Bacterium The Fab portion of IgG binds to epitopes of an antigen. The Fc portion can now attach the antigen to Fc receptors on phagocytes for enhanced attachment. This is especially important against encapsulated microbes. C3b and C4b from the complement pathways can also attach antigens to phagocytes. Once attached to the phagocyte by way of IgG, C3b, or C4b, the microbe can be engulfed more efficiently and placed in a phagosome. As lysosomes fuse with the phagosome the microbe is digested.

  15. Extracellular Killing After Opsonization . The Fab portions of IgG or C3b bind to epitopes on human cells recognized as foreign, such as virus-infected cells, tumor cells, or cells involved in autoimmune reactions. This enables phagocytes to attach to the cell by way of their Fc and C3b receptors. The phagocytes now destroy thecell by discharging their lysosomal contents

  16. Chemotactict effect of C5a and C3b Most C3b binds to antigens on the microbial surface. Some C3b combines with C2a and C4b to form the third enzyme of the complement pathway that is able to split C5 into C5a and C5b. C5a stimulates mast cells to release histamine for inflammation and diapedesis. It also functions as a chemoattractant for phagocytes. The phagocytes are then able to bind to the C3b attached to the surface of themicroorganismallowing for opsonization (enhanced attachement)

  17. Récepteurs du complément Nom Ligand(s) Distribution Fonction CR1(CD35)iC3b, C4b    B, phagocytes, GR, CFD élimination des CI liés aux GRopsonisation activation B CR2(CD21) iC3b, C3dg    B, cellules epitheliales activation B réc. EBV CR3 (CD11b/CD18) iC3b,ICAM-1Phagocytes, NK CFDOpsonine, lectine, adhesion molecule CR4 (CD11c/CD18) iC3b  Phagocytes          molécule d’adhésion opsonisation

  18. Effets cliniques des principaux déficits héréditaires du Complément Déficit Conséquences sur l’act. du C’ Associations cliniques C3 incapacité d’opsonisation Infections à pyogènes incapacité à activer le MAC GN membrano-proliférative C3 Properdine incapacité à former le MAC Infections à Neisseria MAC C1q, C1r, incapacité à activer la voie LES C4, C2 classique

  19. Pathologie du complément - anomalies de régulation Anomalie Clinique Ethiopathogénèse C3 nef -Glomérulonéphrite Auto-Ab qui stabilise le C3bBb membrano-proliférative Déficit en facteur H, I - Glomérulonéphrite Défaut de régulation del’activation membrano-proliférative de C3, avec inflammation chronique - Syndr. Hémolyt. Urém. dans le glomérule et déficit secondaire en C Déficit en C1 inhibiteur- Oedème angioneurotique Défaut de la sérine-protéase qui inactive le C1 et le système de kinines-bradikinines Hémoglobinurie paroxystique - Hémolyse intravasculaire Déficit de régulation du MAC par nocturne défaut d ’expression des molécules GPI (CD55 et CD59)

More Related